Souders Financial Advisors Abb Vie Inc. Transaction History

Souders Financial Advisors

$683 Million
Q3 2024

A detailed history of Souders Financial Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, Souders Financial Advisors holds 22,340 shares of ABBV stock, worth $3.99 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

22,340

Previous 21,924 1.9%

Holding current value

$3.99 Million

Previous $3.76 Million 17.31%

% of portfolio

0.65%

Previous 0.59%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$163.84 - $199.33 $68,157 - $82,921	416 Added 1.9%	22,340 $4.41 Million
Q2 2024 Aug 28, 2024	BUY	$154.79 - $180.76 $142,561 - $166,479	921 Added 4.39%	21,924 $3.76 Million
Q1 2024 May 08, 2024	BUY	$159.82 - $182.1 $2.86 Million - $3.26 Million	17,924 Added 582.14%	21,003 $3.82 Million
Q4 2023 Jan 24, 2024	SELL	$137.6 - $154.97 $275 - $309	-2 Reduced 0.06%	3,079 $477,000
Q3 2023 Nov 06, 2023	BUY	$133.59 - $154.65 $8,282 - $9,588	62 Added 2.05%	3,081 $459,000
Q2 2023 Aug 09, 2023	SELL	$132.51 - $164.9 $3,180 - $3,957	-24 Reduced 0.79%	3,019 $406,000
Q1 2023 May 09, 2023	SELL	$144.61 - $166.54 $15,039 - $17,320	-104 Reduced 3.3%	3,043 $484,000
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $5,532 - $6,634	40 Added 1.29%	3,147 $508,000
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $7,381 - $8,466	55 Added 1.8%	3,107 $417,000
Q2 2022 Aug 05, 2022	BUY	$137.62 - $174.96 $53,947 - $68,584	392 Added 14.74%	3,052 $468,000
Q1 2022 May 04, 2022	BUY	$131.98 - $163.75 $3,959 - $4,912	30 Added 1.14%	2,660 $431,000
Q4 2021 Feb 04, 2022	SELL	$107.43 - $135.93 $3,115 - $3,941	-29 Reduced 1.09%	2,630 $356,000
Q3 2021 Nov 03, 2021	BUY	$106.4 - $120.78 $18,620 - $21,136	175 Added 7.05%	2,659 $287,000
Q2 2021 Aug 09, 2021	BUY	$105.21 - $117.21 $210 - $234	2 Added 0.08%	2,484 $280,000
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $1,329 - $1,464	13 Added 0.53%	2,482 $269,000
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $8,934 - $10,486	104 Added 4.4%	2,469 $244,000
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $173,520 - $232,195	2,365 New	2,365 $232,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Souders Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Souders Financial Advisors with notifications on news.

Account

Souders Financial Advisors Abb Vie Inc. Transaction History